Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaochen Li

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Clinical Genitourinary Cancer|August 21, 2025
Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical CystectomySalvador Jaime-Casas, Miguel Zugman, Regina Barragan-Carrillo, et al.
Frontiers in Oncology|October 23, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinomaSalvador Jaime-Casas, Regina Barragan-Carrillo, Miguel Zugman, et al.
Clinical Genitourinary Cancer|July 26, 2023
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell CarcinomaNazli Dizman, Ameish Govindarajan, Zeynep B Zengin, et al.
JCO Oncology Practice|April 7, 2025
Assessment of Compliance With ASCO Language of Respect Guidelines in Renal Cell Carcinoma AbstractsNazli Dizman, Ruchi Agarwal, Daniela V Castro, et al.
Journal of Integrative Plant Biology|January 21, 2023
High-quality Fagopyrum esculentum genome provides insights into the flavonoid accumulation among different tissues and self-incompatibilityQiang He, Dan Ma, Wei Li, et al.
Cancer Medicine|March 27, 2025
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and InclusionBenjamin D Mercier, Ameish Govindarajan, Daniela V Castro, et al.
BJU International|August 7, 2023
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapyDaniela V Castro, Sweta R Prajapati, Matthew I Feng, et al.
Cancers|June 12, 2026
Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial AvailabilityKoral U Shah, Daniela V Castro, Xiaochen Li, et al.
Nature Medicine|June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialHedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Journal of Thoracic Disease|July 10, 2020
Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational studyFan Wu, Yumin Zhou, Zhongfang Wang, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Clinical Genitourinary Cancer|August 21, 2025
Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical CystectomySalvador Jaime-Casas, Miguel Zugman, Regina Barragan-Carrillo, et al.
Frontiers in Oncology|October 23, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinomaSalvador Jaime-Casas, Regina Barragan-Carrillo, Miguel Zugman, et al.
Clinical Genitourinary Cancer|July 26, 2023
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell CarcinomaNazli Dizman, Ameish Govindarajan, Zeynep B Zengin, et al.
JCO Oncology Practice|April 7, 2025
Assessment of Compliance With ASCO Language of Respect Guidelines in Renal Cell Carcinoma AbstractsNazli Dizman, Ruchi Agarwal, Daniela V Castro, et al.
Journal of Integrative Plant Biology|January 21, 2023
High-quality Fagopyrum esculentum genome provides insights into the flavonoid accumulation among different tissues and self-incompatibilityQiang He, Dan Ma, Wei Li, et al.
Cancer Medicine|March 27, 2025
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and InclusionBenjamin D Mercier, Ameish Govindarajan, Daniela V Castro, et al.
BJU International|August 7, 2023
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapyDaniela V Castro, Sweta R Prajapati, Matthew I Feng, et al.
Cancers|June 12, 2026
Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial AvailabilityKoral U Shah, Daniela V Castro, Xiaochen Li, et al.
Nature Medicine|June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialHedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Journal of Thoracic Disease|July 10, 2020
Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational studyFan Wu, Yumin Zhou, Zhongfang Wang, et al.
Pageof 29